92 related articles for article (PubMed ID: 28791994)
21. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
22. The expression of GLTSCR2, a candidate tumor suppressor, is reduced in seborrheic keratosis compared to normal skin.
Kim JY; Kim HS; Lee S; Park JH
Pathol Res Pract; 2010 May; 206(5):295-9. PubMed ID: 20185249
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of epidermal growth factor receptor induces sequestration of extracellular signal-related kinases and selective attenuation of specific epidermal growth factor-mediated signal transduction pathways.
Habib AA; Chun SJ; Neel BG; Vartanian T
Mol Cancer Res; 2003 Jan; 1(3):219-33. PubMed ID: 12556561
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor (EGF) receptor carboxy-terminal domains are required for EGF-induced glucose transport in transgenic 3T3-L1 adipocytes.
Hardy RW; Gupta KB; McDonald JM; Williford J; Wells A
Endocrinology; 1995 Feb; 136(2):431-9. PubMed ID: 7835273
[TBL] [Abstract][Full Text] [Related]
25. Hepatocyte growth factor induces resistance to anti-epidermal growth factor receptor antibody in lung cancer.
Yamada T; Takeuchi S; Kita K; Bando H; Nakamura T; Matsumoto K; Yano S
J Thorac Oncol; 2012 Feb; 7(2):272-80. PubMed ID: 22089117
[TBL] [Abstract][Full Text] [Related]
26. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells.
Asanuma H; Torigoe T; Kamiguchi K; Hirohashi Y; Ohmura T; Hirata K; Sato M; Sato N
Cancer Res; 2005 Dec; 65(23):11018-25. PubMed ID: 16322251
[TBL] [Abstract][Full Text] [Related]
27. Study on the correlation of high expression level of HuD with seborrheic keratosis and skin aging.
Chen J; Liu J; Wang Z; Xu J; Tao J; Li H
J Cosmet Dermatol; 2022 Dec; 21(12):7043-7049. PubMed ID: 36065721
[TBL] [Abstract][Full Text] [Related]
28. GPCR agonist-induced transactivation of the EGFR upregulates MLC II expression and promotes hypertension in insulin-resistant rats.
Nagareddy PR; MacLeod KM; McNeill JH
Cardiovasc Res; 2010 Jul; 87(1):177-86. PubMed ID: 20110336
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis.
Gaballah MA; Ahmed RA
Pathol Res Pract; 2015 Dec; 211(12):931-8. PubMed ID: 26573127
[TBL] [Abstract][Full Text] [Related]
30. Expression of epidermal growth factor (EGF), its receptor, and related oncoprotein (erbB-2) in human pituitary tumors and response to EGF in vitro.
Chaidarun SS; Eggo MC; Sheppard MC; Stewart PM
Endocrinology; 1994 Nov; 135(5):2012-21. PubMed ID: 7956924
[TBL] [Abstract][Full Text] [Related]
31. Epidermal growth factor receptor regulates aberrant expression of insulin-like growth factor-binding protein 3.
Takaoka M; Harada H; Andl CD; Oyama K; Naomoto Y; Dempsey KL; Klein-Szanto AJ; El-Deiry WS; Grimberg A; Nakagawa H
Cancer Res; 2004 Nov; 64(21):7711-23. PubMed ID: 15520175
[TBL] [Abstract][Full Text] [Related]
32. Increased TGF-α as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.
Troiani T; Martinelli E; Napolitano S; Vitagliano D; Ciuffreda LP; Costantino S; Morgillo F; Capasso A; Sforza V; Nappi A; De Palma R; D'Aiuto E; Berrino L; Bianco R; Ciardiello F
Clin Cancer Res; 2013 Dec; 19(24):6751-65. PubMed ID: 24122793
[TBL] [Abstract][Full Text] [Related]
33. Epidermal growth factor receptor--its expression and copy numbers of EGFR gene in patients with head and neck squamous cell carcinomas.
Mrhalova M; Plzak J; Betka J; Kodet R
Neoplasma; 2005; 52(4):338-43. PubMed ID: 16059652
[TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor receptor pathway mutation and expression profiles in cervical squamous cell carcinoma: therapeutic implications.
Bumrungthai S; Munjal K; Nandekar S; Cooper K; Ekalaksananan T; Pientong C; Evans MF
J Transl Med; 2015 Jul; 13():244. PubMed ID: 26209091
[TBL] [Abstract][Full Text] [Related]
35. [Study of hormone responsiveness of the adenylyl cyclase signaling system in erythrocyte membranes of patients with type 2 diabetes mellitus].
Kuznetsova LA; Plesneva SA; Sharova TC; Pertseva MN
Patol Fiziol Eksp Ter; 2013; (1):45-9. PubMed ID: 23805714
[TBL] [Abstract][Full Text] [Related]
36. Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer's disease.
Kapogiannis D; Boxer A; Schwartz JB; Abner EL; Biragyn A; Masharani U; Frassetto L; Petersen RC; Miller BL; Goetzl EJ
FASEB J; 2015 Feb; 29(2):589-96. PubMed ID: 25342129
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanisms of insulin resistance that impact cardiovascular biology.
Wang CC; Goalstone ML; Draznin B
Diabetes; 2004 Nov; 53(11):2735-40. PubMed ID: 15504952
[TBL] [Abstract][Full Text] [Related]
38. Expression of functional epidermal growth factor receptors in a human hematopoietic cell line.
Oval J; Hershberg R; Gansbacher B; Gilboa E; Schlessinger J; Taetle R
Cancer Res; 1991 Jan; 51(1):150-6. PubMed ID: 1703031
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma.
Buckley AF; Burgart LJ; Kakar S
Hum Pathol; 2006 Apr; 37(4):410-4. PubMed ID: 16564914
[TBL] [Abstract][Full Text] [Related]
40. Synergistic effects of metformin in combination with EGFR-TKI in the treatment of patients with advanced non-small cell lung cancer and type 2 diabetes.
Chen H; Yao W; Chu Q; Han R; Wang Y; Sun J; Wang D; Wang Y; Cao M; He Y
Cancer Lett; 2015 Dec; 369(1):97-102. PubMed ID: 26341687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
